Status:

RECRUITING

Overcoming Therapy Resistance in ER+ Breast Cancer Patients: a Translational Project (OVERTuRE)

Lead Sponsor:

Centro di Riferimento Oncologico - Aviano

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

Patients presenting with a de novo diagnosis of luminal-like advanced breast cancer (ABC) or with disease recurrence after \>12 months from the end of adjuvant ET, are generally candidate to a first l...

Detailed Description

Patients presenting with a de novo diagnosis of luminal-like advanced breast cancer (ABC) or with disease recurrence after \>12 months from the end of adjuvant ET, are generally candidate to a first l...

Eligibility Criteria

Inclusion

  • Histologically proven diagnosis of adenocarcinoma of the breast with evidence of metastatic disease.
  • ER positive tumor ≥ 1%
  • HER2 negative breast cancer by FISH or IHC (IHC 0,1+, 2+ and/or FISH HER2: CEP17 ratio \< 2.0)
  • Females, 18 years of age or older
  • Candidate to first-line endocrine therapy (LH-RH analogue for pre-menopausal women is allowed)
  • Signed and dated informed consent document indicating that the subject (or legally acceptable representative) has been informed of all the pertinent aspects of the trial prior to enrollment.
  • Willingness and ability to comply with scheduled visits, treatment plan, laboratory tests, and other trial procedures.

Exclusion

  • Diagnosis of any secondary malignancy within the last 3 years, except for adequately treated basal cell or squamous cell skin cancer, or carcinoma in situ of the cervix.
  • Prior endocrine therapy for metastatic disease
  • Prior chemotherapy for metastatic disease
  • Patients unwilling to or unable to comply with the protocol.
  • Known CNS metastases

Key Trial Info

Start Date :

May 18 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 18 2026

Estimated Enrollment :

74 Patients enrolled

Trial Details

Trial ID

NCT06129786

Start Date

May 18 2023

End Date

May 18 2026

Last Update

November 13 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Centro di Riferimento Oncologico (CRO) di aviano-IRCCS

Aviano, Pordenone, Italy, 33081

2

Azienda Sanitaria Universitaria del Friuli Centrale(ASUFC)

Udine, Italy, 33100